Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
An in vitro hepatitis C virus (HCV) replication system that is capable of producing viral particles in a culture medium More
Aerosolized immunogenic compositions that may prove useful for vaccination against respiratory infections and may provide a platform for generating mucosal antibody responses against other pathogens. More
A variety of new toxoids useful as botulinum vaccine antigens, for BAT or BIG production, or for development of tests to evaluate antigenicity of botulinum vaccines More
Hybridoma cell lines capable of expressing monoclonal antibodies against FHA More
A mechanism for augmenting the immune response against HEV in infected individuals More
Use of Shewanella CPS conjugates as a component of an anthrax vaccine More
Related Reports
Market Research Reports provided by reports.innovaro.com
Nov 2010 - 40 pages - $500
Dec 2010 - 28 pages - $500
May 2011 - 150 pages - $3,995
May 2009 - 131 pages - $3,800
Mar 2011 - 32 pages - $250
Mar 2010 - 39 pages - $2,000
Nov 2011 - 7 pages - $3,835
Oct 2010 - 45 pages - $2,000
Sep 2010 - 46 pages - $2,000
Jun 2006 - 1458 pages - $2,495
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2012 Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us